SightLine Partners — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

EndoGastric Solutionsendogastricsolutions.com 𝕏Jul 2018 · $30.5M

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in

Board Michael Carusi(Director)inArda Minocherhomjee(Director)

Co-investorsAccelmed Partners Canaan Partners Evidity Health Capital Lightstone Ventures VCFA Group Advanced Technology Ventures +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.